Cancer Treatment Reviews
Volume 35, Issue 7 , Pages 633-638, November 2009

Trastuzumab versus lapatinib: The cardiac side of the story

  • Hamdy Azim

      Affiliations

    • Department of Clinical Oncology, Cairo University Hospital, Cairo, Egypt
    • ,
  • Hatem A. Azim Jr.

      Affiliations

    • Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
    • Corresponding Author InformationCorresponding author. Tel.: +20 2 33026814; fax: +20 2 33028656.
    • ,
  • Bernard Escudier

      Affiliations

    • Department of Oncology, Institute Gustave Roussy, Villejuif, Paris, France

Received 5 April 2009; received in revised form 15 June 2009; accepted 22 June 2009. published online 29 July 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(09)00094-2

doi:10.1016/j.ctrv.2009.06.007

Cancer Treatment Reviews
Volume 35, Issue 7 , Pages 633-638, November 2009

Article Tools

* Image Usage & Resolution